Continuous Monitoring of Left Atrial Pressure during MitraClip, Regardless Echocardiography

The aim of this study was to assess the use of measuring left atrial pressure to complement transesophageal echocardiography and doppler imaging.

MitraClip: ¿debemos intervenir antes a nuestros pacientes?Procedure efficacy is measured in the cath lab by echocardiography. However, these measurements are operator dependent and might be influenced by left ventricular function and changes in left atrial compliance.

 

The study looked at continuous left sided pressure in 50 patients undergoing MitraClip. These measurements included left atrial V-wave pressure, and left atrial mean, systolic, and end-diastolic pressures. Left atrial pressures were indexed to left ventricular pressures to compensate for variations in afterload during procedure.


Read also: TCT 2018 | TriValve: Mitraclip for the Tricuspid Valve.


70% of patients had degenerative mitral regurgitation. Mitral regurgitation grade by echocardiography decreased from 3+ to 0+, and atrial V-wave (p<0.001), mean left atrial pressure (p=0.007), end diastolic pressure (p=0.001) and all left atrial pressures indexed values also decreased after MitraClip.

 

Intra-procedural increase of mean left atrial pressure was associated to a smaller number of rehospitalizations for cardiac failure and more chances to reach functional class III or IV at follow-up. These events could not be predicted by post procedure 2+ mitral regurgitation.

 

Conclusions

This study shows the value of continued real-time monitoring of left atrial pressure to predict events after treating mitral regurgitation with MitraClip. An increase in left atrial mean pressure is a predictor of worse prognosis at short term, regardless echocardiographic findings.

 

Original title: Continuous Direct Left Atrial Pressure. Intraprocedural Measurement Predicts Clinical Response Following MitraClip Therapy.

Reference: Shingo Kuwata et al. J Am Coll Cardiol Intv 2019, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...